LEXINGTON, Mass.--(BUSINESS WIRE)--Aug. 29, 2006--Critical Therapeutics, Inc. (Nasdaq: CRTX), a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases, today announced that Frank Thomas, President of Critical Therapeutics, will provide an update on the Company's strategy, operations and development pipeline at the following investor conferences:
